Compare HKD & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HKD | NPCE |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 531.1M | 536.6M |
| IPO Year | 2021 | 2021 |
| Metric | HKD | NPCE |
|---|---|---|
| Price | $1.72 | $15.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $18.33 |
| AVG Volume (30 Days) | ★ 266.3K | 122.4K |
| Earning Date | 02-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $99,986,000.00 |
| Revenue This Year | N/A | $0.90 |
| Revenue Next Year | N/A | $24.46 |
| P/E Ratio | $14.10 | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $1.26 | $7.56 |
| 52 Week High | $5.47 | $19.60 |
| Indicator | HKD | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 50.46 | 45.02 |
| Support Level | $1.60 | $15.40 |
| Resistance Level | $1.90 | $15.71 |
| Average True Range (ATR) | 0.11 | 0.77 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 20.45 | 11.77 |
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment; hotel operations, hospitality and VIP services segment; media and entertainment services segment; and Strategic investments. The company generates maximum revenue from Digital solutions services segment, which provides its institutional and corporate clients with exclusive, paid access to enhance their investor communication, investor relations and corporate communication to potentially maximize their valuation, as well as providing digital solution services. Geographically, the company generates revenue from China, Hong Kong, Europe, Americas and Southeast Asia.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.